Immunologic hurdles of therapeutic stem cell transplantation

Biological Chemistry

Volumn 390, Issue 10, 2009, Pages 977-983

  Utermöhlen, Olaf ^a   Baschuk, Nikola ^a   Abdullah, Zeinab ^a,c   Engelmann, Afra ^b,d   Siebolts, Udo ^a,e   Wickenhauser, Claudia ^a,e   Stocking, Carol ^b   Krönke, Martin ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF HAMBURG   (Germany)

^c UNIVERSITY OF BONN   (Germany)

^d CHILDREN'S MEDICAL RESEARCH INSTITUTE   (Australia)

^e UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Cytotoxic T lymphocyte; Embryonic stem cell; Natural killer cell; Teratoma

Indexed keywords

SERINE PROTEINASE INHIBITOR;

ADULT STEM CELL; ALLOGENEIC STEM CELL TRANSPLANTATION; CD8+ T LYMPHOCYTE; CELL PROTECTION; CELL REGENERATION; CYTOTOXIC T LYMPHOCYTE; EMBRYONIC STEM CELL; HUMAN; IMMUNOBIOLOGY; IMMUNOCOMPETENCE; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; STEM CELL TRANSPLANTATION;

ADULT; ADULT STEM CELLS; ANIMALS; EMBRYONIC STEM CELLS; HUMANS; KILLER CELLS, NATURAL; REGENERATIVE MEDICINE; STEM CELL TRANSPLANTATION; T-LYMPHOCYTES;

EID: 70349329563     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2009.114     Document Type: Review

References (44)

1. Abdullah, Z., Saric, T., Kashkar, H., Baschuk, N., Yazdanpanah, B., Fleischmann, B.K., Hescheler, J., Krönke, M., and Uter-möhlen, O. (2007). Serpin-6 expression protects embryonic stem cells from lysis by antigen-specific CTL. J. Immunol. 178, 3390-3399.
2. Andrews, P.W., Matin, M.M., Bahrami, A.R., Damjanov, I., Gok-hale, P., and Draper, J.S. (2005). Embryonic stem (ES) cells and embryonal carcinoma (EC) cells: opposite sides of the same coin. Biochem. Soc. Trans. 33, 1526-1530.
3. Barrie, M.B., Stout, H.W., Abougergi, M.S., Miller, B.C., and Thiele, D.L. (2004). Antiviral cytokines induce hepatic expression of the granzyme B inhibitors, proteinase inhibitor 9 and serine proteinase inhibitor 6. J. Immunol. 172, 6453-6459.
4. Bladergroen, B.A., Meijer, C.J., ten Berge, R.L., Hack, C.E., Muris, J.J., Dukers, D.F., Chott, A., Kazama, Y., Oudejans, J.J., van Berkum, O., et al. (2002). Expression of the gran-zyme B inhibitor, protease inhibitor 9, by tumor cells in patients with non-Hodgkin and Hodgkin lymphoma: a novel protective mechanism for tumor cells to circumvent the immune system? Blood 99, 232-237.
5. Bonde, S. and Zavazava, N. (2006). Immunogenicity and engraft-ment of mouse embryonic stem cells in allogeneic recipients. Stem Cells 24, 2192-2201.
6. Bradley, J.A., Bolton, E.M., and Pedersen, R.A. (2002). Stem cell medicine encounters the immune system. Nat. Rev. Immunol. 2, 859-871.
7. Burt, R.K., Verda, L., Kim, D.A., Oyama, Y., Luo, K., and Link, C. (2004). Embryonic stem cells as an alternate marrow donor source: engraftment without graft-versus-host disease. J. Exp. Med. 199, 895-904.
8. Damjanov, I. (2004). From stem cells to germ cell tumors and back. Verh. Dtsch. Ges. Pathol. 88, 39-44.
9. David-Watine, B., Transy, C., Gachelin, G., and Kourilsky, P. (1987). Tissue-specific expression of the mouse Q10 H-2 class-I gene during embryogenesis. Gene 61, 145-154.
10. Draper, J.S., Pigott, C., Thomson, J.A., and Andrews, P.W. (2002). Surface antigens of human embryonic stem cells: changes upon differentiation in culture. J. Anat. 200, 249-258.
11. Dressel, R., Schindehutte, J., Kuhlmann, T., Elsner, L., Novota, P., Baier, P.C., Schillert, A., Bickeboller, H., Herrmann, T., Trenkwalder, C., et al. (2008). The tumorigenicity of mouse embryonic stem cells and in vitro differentiated neuronal cells is controlled by the recipients' immune response. PLoS ONE 3, e2622.
12. Drukker, M., Katchman, H., Katz, G., Even-Tov Friedman, S., Shezen, E., Hornstein, E., Mandelboim, O., Reisner, Y., and Benvenisty, N. (2006). Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells. Stem Cells 24, 221-229.
13. Drukker, M., Katz, G., Urbach, A., Schuldiner, M., Markel, G., Itskovitz-Eldor, J., Reubinoff, B., Mandelboim, O., and Ben-venisty, N. (2002). Characterization of the expression of MHC proteins in human embryonic stem cells. Proc. Natl. Acad. Sci. USA 99, 9864-9869.
14. Fabricius, D., Bonde, S., and Zavazava, N. (2005). Induction of stable mixed chimerism by embryonic stem cells requires functional Fas/FasL engagement. Transplantation 79, 1040-1044.
15. Frenzel, L.P., Abdullah, Z., Kriegeskorte, A.K., Dieterich, R., Lange, N., Busch, D.H., Krönke, M., Utermöhlen, O., Hes-cheler, J., and Saric, T. (2009). Role of natural-killer group 2 member D ligands and intercellular adhesion molecule 1 in natural killer cell-mediated lysis of murine embryonic stem cells and embryonic stem cell-derived cardiomyocytes. Stem Cells 27, 307-316.
16. Guidotti, L.G., Ando, K., Hobbs, M.V., Ishikawa, T., Runkel, L., Schreiber, R.D., and Chisari, F.V. (1994). Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncy-tolytic mechanism in transgenic mice. Proc. Natl. Acad. Sci. USA 91, 3764-3768.
17. Guidotti, L.G., Ishikawa, T., Hobbs, M.V., Matzke, B., Schreiber, R., and Chisari, F.V. (1996). Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 4, 25-36.
18. Koch, C.A. and Platt, J.L. (2007). T cell recognition and immunity in the fetus and mother. Cell. Immunol. 248, 12-17.
19. Koch, C.A., Geraldes, P., and Platt, J.L. (2008). Immunosup-pression by embryonic stem cells. Stem Cells 26, 89-98.
20. Kofidis, T., deBruin, J.L., Tanaka, M., Zwierzchoniewska, M., Weissman, I., Fedoseyeva, E., Haverich, A., and Robbins, R.C. (2005). They are not stealthy in the heart: embryonic stem cells trigger cell infiltration, humoral and T-lymphocyte-based host immune response. Eur. J. Cardiothorac. Surg. 28, 461-466.
21. Laskarin, G., Kammerer, U., Rukavina, D., Thomson, A.W., Fernandez, N., and Blois, S.M. (2007). Antigen-presenting cells and materno-fetal tolerance: an emerging role for dendritic cells. Am. J. Reprod. Immunol. 58, 255-267.
22. Li, L., Baroja, M.L., Majumdar, A., Chadwick, K., Rouleau, A., Gallacher, L., Ferber, I., Lebkowski, J., Martin, T., Madrenas, J., et al. (2004). Human embryonic stem cells possess immune-privileged properties. Stem Cells 22, 448-456.
23. Ljunggren, H.G. and Karre, K. (1990). In search of the 'missing self': MHC molecules and NK cell recognition. Immunol. Today 11, 237-244.
24. Magliocca, J.F., Held, I.K., and Odorico, J.S. (2006). Undifferen-tiated murine embryonic stem cells cannot induce portal tolerance but may possess immune privilege secondary to reduced major histocompatibility complex antigen expression. Stem Cells Dev. 15, 707-717.
25. Medema, J.P., de Jong, J., Peltenburg, L.T., Verdegaal, E.M., Gorter, A., Bres, S.A., Franken, K.L., Hahne, M., Albar, J.P., Melief, C.J., et al. (2001a). Blockade of the granzyme B/per-forin pathway through overexpression of the serine protease inhibitor PI-9/SPI-6 constitutes a mechanism for immune escape by tumors. Proc. Natl. Acad. Sci. USA 98, 11515-11520.
26. Medema, J.P., Schuurhuis, D.H., Rea, D., van Tongeren, J., de Jong, J., Bres, S.A., Laban, S., Toes, R.E., Toebes, M., Schumacher, T.N., et al. (2001b). Expression of the serpin serine protease inhibitor 6 protects dendritic cells from cytotoxic T lymphocyte-induced apoptosis: differential modulation by T helper type 1 and type 2 cells. J. Exp. Med. 194, 657-667.
27. Menard, C., Hagege, A.A., Agbulut, O., Barro, M., Morichetti, M.C., Brasselet, C., Bel, A., Messas, E., Bissery, A., Bruneval, P., et al. (2005). Transplantation of cardiac-committed mouse embryonic stem cells to infarcted sheep myocardium: a pre-clinical study. Lancet 366, 1005-1012.
28. Min, J.Y., Yang, Y., Sullivan, M.F., Ke, Q., Converso, K.L., Chen, Y., Morgan, J.P., and Xiao, Y.F. (2003). Long-term improvement of cardiac function in rats after infarction by transplantation of embryonic stem cells. J. Thorac. Cardiovasc. Surg. 125, 361-369.
29. Moffett, A. and Loke, C. (2006). Immunology of placentation in eutherian mammals. Nat. Rev. Immunol. 6, 584-594.
30. Morello, D., Duprey, P., Israel, A., and Babinet, C. (1985). Asynchronous regulation of mouse H-2D and b-2 microglobulin RNA transcripts. Immunogenetics 22, 441-452.
31. Nussbaum, J., Minami, E., Laflamme, M.A., Virag, J.A., Ware, C.B., Masino, A., Muskheli, V., Pabon, L., Reinecke, H., and Murry, C.E. (2007). Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response. FASEB J. 21, 1345-1357.
32. Ozato, K., Wan, Y.J., and Orrison, B.M. (1985). Mouse major histocompatibility class I gene expression begins at midso-mite stage and is inducible in earlier-stage embryos by inter-feron. Proc. Natl. Acad. Sci. USA 82, 2427-2431.
33. Riley, J.K. (2008). Trophoblast immune receptors in maternal-fetal tolerance. Immunol. Invest. 37, 395-426.
34. Robertson, N.J., Brook, F.A., Gardner, R.L., Cobbold, S.P., Wald-mann, H., and Fairchild, P.J. (2007). Embryonic stem cell-derived tissues are immunogenic but their inherent immune privilege promotes the induction of tolerance. Proc. Natl. Acad. Sci. USA 104, 20920-20925.
35. Rukavina, D. and Podack, E.R. (2000). Abundant perforin expression at the maternal-fetal interface: guarding the semiallogeneic transplant? Immunol. Today 21, 160-163.
36. Rukavina, D., Rubesa, G., Gudelj, L., Haller, H., and Podack, E.R. (1995). Characteristics of perforin expressing lymphocytes within the first trimester decidua of human pregnancy. Am. J. Reprod. Immunol. 33, 394-404.
37. Sayers, T.J., Brooks, A.D., Ward, J.M., Hoshino, T., Bere, W.E., Wiegand, G.W., Kelly, J.M., and Smyth, M.J. (2001). The restricted expression of granzyme M in human lymphocytes. J. Immunol. 166, 765-771.
38. Swijnenburg, R.J., Tanaka, M., Vogel, H., Baker, J., Kofidis, T., Gunawan, F., Lebl, D.R., Caffarelli, A.D., de Bruin, J.L., Fedo-seyeva, E.V., et al. (2005). Embryonic stem cell immunoge-nicity increases upon differentiation after transplantation into ischemic myocardium. Circulation 112, I166-172.
39. Teramoto, K., Hara, Y., Kumashiro, Y., Chinzei, R., Tanaka, Y., Shimizu-Saito, K., Asahina, K., Teraoka, H., and Arii, S. (2005). Teratoma formation and hepatocyte differentiation in mouse liver transplanted with mouse embryonic stem cell-derived embryoid bodies. Transplant Proc. 37, 285-286.
40. Tian, L., Catt, J.W., O'Neill, C., and King, N.J. (1997). Expression of immunoglobulin superfamily cell adhesion molecules on murine embryonic stem cells. Biol. Reprod. 57, 561-568.
41. Utermöhlen, O. and Krönke, M. (2007). Survival of priceless cells: active and passive protection of embryonic stem cells against immune destruction. Arch. Biochem. Biophys. 462, 273-277.
42. van Houdt, I.S., Oudejans, J.J., van den Eertwegh, A.J., Baars, A., Vos, W., Bladergroen, B.A., Rimoldi, D., Muris, J.J., Hooij-berg, E., Gundy, C.M., et al. (2005). Expression of the apop-tosis inhibitor protease inhibitor 9 predicts clinical outcome in vaccinated patients with stage III and IV melanoma. Clin. Cancer Res. 11, 6400-6407.
43. Wobus, A.M., Holzhausen, H., Jakel, P., and Schoneich, J. (1984). Characterization of a pluripotent stem cell line derived from a mouse embryo. Exp. Cell Res. 152, 212-219.
44. Yokoyama, W.M. (2005). Natural killer cell immune responses. Immunol. Res. 32, 317-325.